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A B S T R A C T
The present work aims to characterize and investigate the anti-inflammatory activity of hop extracts (cv.
Cascade) in an in vitro model of gastric inflammation. The biological activities of hydroalcoholic and aqueous
extracts from cones were evaluated by comparing IL-8 inhibition induced by TNFα. The hydroalcoholic extract
demonstrated a higher inhibitory effect, which was just slightly affected by an in vitro simulated gastric diges-
tion. The identification of active compounds was performed by a bio-guided fractionation which afforded 11
fractions, one of which inhibited IL-8 release in a concentration-dependent fashion in human gastric epithelial
AGS cells. Phytochemical analysis revealed xanthohumol A and xanthohumol D as the main active components.
The present study provides some experimental evidences that Humulus lupulus L. may exert an anti-inflammatory
activity on the gastric district by the inhibition of the IL-8 secretion, partially due to its prenylated chalcones
content.
1. Introduction
Chronic gastritis is a common disease which represents an im-
portant background for the development of several gastric pathologies.
Some of the most serious consequences of a prolonged inflammation at
gastric level are peptic ulcers (Chuah et al., 2014) and cancer (Chen
et al., 2016; Ohata et al., 2004). Despite a decline in the incidence in the
past decades, stomach cancer has been estimated in more than
1,000,000 new cases and responsible for 783,000 deaths worldwide just
in 2018 (Bray et al., 2018). Helicobacter pylori infection represents a
major risk factor in this context (Chen et al., 2016), since this Gram
negative bacterium colonizes the gastric mucosa of over 50% of the
world human population (Rugge et al., 2011) and induces a persistent
immune response in the host (Crabtree, 1996), which is characterized
by the release of several inflammatory cytokines in the gastric mucosa,
including IL-8 and TNFα (Crabtree, Shallcross, Heatley, & Wyatt, 1991;
Gionchetti et al., 1994; Moss, Legon, Davies, & Calam, 1994; Noach
et al., 1994). When exposed to TNFα, gastric epithelial cells release IL-
8, a potent chemokine promoting neutrophil infiltration (Crabtree
et al., 1994; Yasumoto et al., 1992a,b; Sharma, Tummuru, Miller, &
Blaser, 1995), through activation of NF-κB (Choi et al., 2006; Yasumoto
et al., 1992a,b), a transcription factor deeply involved in the in-
flammatory processes (Barkett & Gilmore, 1999; Bonizzi & Karin, 2004;
Shishodia & Aggarwal, 2004). IL-8 levels in the gastric mucosa has been
positively associated with the severity of gastritis (Xuan et al., 2005)
and the serum levels of this chemokine correlate with the degree of
gastric chronic inflammation and neutrophil infiltration (Siregar,
Halim, & Sitepu, 2015), making this molecule an ideal marker to
evaluate the gastric inflammatory state. Since IL-8 contributes to the
amplification of the inflammation, the search for new extracts or nat-
ural leads able to inhibit this chemokine could be a strategy to prevent
more severe clinical outcomes.
Hops (Humulus lupulus L., Cannabaceae) is a plant extensively used
in human nutrition, in particular for the production of beer, in which
the female inflorescences are used to provide the typical bitterness and
aroma. Despite the consumption of beer is not recommended for human
gastric inflammation, due to its alcohol content and relative pro-oxi-
dant effects (de Gaetano et al., 2016), hops, as ingredients of food
https://doi.org/10.1016/j.jff.2019.03.041
Received 25 January 2019; Received in revised form 23 March 2019; Accepted 23 March 2019
⁎ Corresponding author.
E-mail address: enrico.sangiovanni@unimi.it (E. Sangiovanni).
Journal of Functional Foods 57 (2019) 95–102
1756-4646/ © 2019 Elsevier Ltd. All rights reserved.
T
supplements, are considered an interesting source of bioactive com-
pounds, such as xanthohumol A (Fig. 1A), a prenylated chalcone that
has shown anti-inflammatory activity in different experimental models
(Cho et al., 2008; Dorn, Heilmann, & Hellerbrand, 2012; Dorn, Kraus
et al., 2010; Lee et al., 2011). The consumption of hop-based products is
increasing, and hops are not only ingredients in food supplements, but
also important component of non-alcoholic beverages. There is a par-
ticular interest in the research of hops active components; despite the
high consumption of hops in human diet, only few studies investigated
their possible beneficial effects at the gastric level.
The intragastric administration of a commercial hop dry extract in a
rat pylorus-ligated model increased gastric juice volume without af-
fecting acidity, a mechanism mediated by cholinergic nervous system
that could positively affect the digestion process (Kurasawa,
Chikaraishi, Naito, Toyoda, & Notsu, 2005). Two studies described the
effect of hops against Helicobacter pylori. In the first study, fresh hops
homogenates from three different varieties inhibited in vitro the growth
of a clinical isolated bacterium and the effect was partly attributed to
their content in α- and β-acids (Cermak et al., 2015). In the second
study, a high molecular weight fraction from hop bract extract, rich in
polymerized catechins, reduced in mice the gastric damage induced by
the oral administration of VacA, a vacuolating cytotoxin produced by
Helicobacter pylori (Yahiro et al., 2005). As anti-inflammatory effects, a
CO2 hop extract reduced the prostaglandin E2 production in adeno-
carcinoma gastric cells (AGS) by influencing COX-2 enzyme (Tripp,
Darland, Lerman, Lukaczer, Bland, & Babish, 2005), while xantho-
humol A suppressed the proliferation, apoptosis and metastasis of AGS
cells via induction of ROS production and inhibition of the NF-κB sig-
naling (Wei et al., 2018).
In a previous study by our group, the hop cultivar Cascade, a highly
appreciated cultivar, was phytochemically characterized with the dis-
covery of three new minor constituents, 4-hydroxycolupulone, humu-
difucol, and cascadone (Forino et al., 2016). In addition, xanthohumol
A was found to inhibit the activity of two important pro-inflammatory
enzymes, microsomal prostaglandin E2 synthase (mPGES)-1 and 5-li-
poxygenase (5-LO) (Forino et al., 2016).
On these bases, the present work aimed at deepening the in-
vestigation on the anti-inflammatory potential of cv. Cascade hop in
gastric epithelial cells, possibly identifying the molecule(s) responsible
for the effect. Attention has been paid to the extract ability to inhibit IL-
8 release by gastric epithelial cells, investigating the NF-κB pathway as
well.
2. Material and methods
2.1. General experimental procedures
Dulbecco’s Modified Eagle’s Medium/F12 (DMEM)/F12 (1:1), pe-
nicillin, streptomycin, L-glutamine and trypsin-EDTA were from Gibco
(Life Technologies Italia, Monza, Italy). Foetal bovine serum (FBS), and
disposable materials for cell culture were purchased by Euroclone
(Euro- clone S.p.A., Pero-Milan, Italy). Human adenocarcinoma cells
(AGS, CRL-1739) were purchased from LGC Standard S.r.l., Milano,
Italy.
The reagent 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) and curcumin were from Sigma Aldrich (Milan, Italy).
All reagents used for the biological assays were HPLC grade. Human
TNFα and Human IL-8 Elisa Development Kit were from Peprotech Inc.
(London, UK). All chromatographic solvents were HPLC grade or LC-MS
grade for MS experiments. Acetonitrile, methanol, ethanol, formic acid,
hydrochloric acid, vanillin, and iron sulfate were from Sigma Aldrich
(Milan, Italy).
NMR experiments were run on Varian Unity Inova 700 spectrometer
equipped with a 13C Enhanced HCN Cold Probe and by using Shigemi
5mm NMR tubes. HPLC-RI separations were performed on a Knauer
(Berlin, Germany) 1800 apparatus equipped with a refractive index
detector.
2.2. Plant material
Hop plantlets were purchased at Garten Eickelmann (Geisenfeld,
Germany) and cultivated for four years in an experimental site (Farm La
Morosina, Abbiategrasso, Milan, Italy) and collected in 2014. Cones,
collected at maturity, were dried at 40 °C in a thermostatic room,
protected from light. A voucher specimen was deposited at the
Herbarium of the Botanical Garden GE Ghirardi, Department of
Pharmaceutical Sciences, University of Milan, with number Hl 101.
2.3. Preparation of the extracts
Before extraction, hop cones were kept at 4 °C to limit the chemical
and enzymatic reactions. Subsequently the drug (20 g) was dried in an
oven at 40 °C for 24 h and, the following day, the dried cones were
pulverized using a mortar and a pestle. The obtained powder was stored
inside an amber glass bottle at 4 °C. To obtain the extracts, 3 g of
powder were extracted twice with 30mL of water (aqueous extract) or
30mL of ethanol/water 50:50 (hydroalcoholic extract) for 4 and 16 h,
respectively, at room temperature under dark conditions. The mixture
was filtered through Supervelox filter paper to remove plant debris;
solvents were evaporated using a Rotavapor system and extracts con-
taining water were frozen with dry ice and alcohol and placed
at− 80 °C overnight, then lyophilized and maintained at− 20 °C. The
yields (w/w) of each extraction were calculated as percentage ratio
between the dried extract weight and the weight of the fresh starting
material. Stock solutions of the extracts were prepared, aliquoted at
25mg/mL and kept at −20 °C; aqueous extract was solved in a mixture
of water/DMSO (50:50), while hydroalcoholic extract used an ethanol/
water mixture (50:50).
2.4. Fractionation of the hydroalcoholic extract
A sample of the inflorescences of H. lupulus cultivar Cascade (30 g),
was triturated and extracted three times with 500mL of H2O or with
500mL of EtOH/H2O (1:1) (v/v) mixture. The extracts were combined
and evaporated, and the resulting residue was separated on a MPLC
(Buchi) silica gel (230–400 mesh) column (460mm×70mm) eluted
with a stepwise gradient of n-hexane to EtOAc and then to MeOH. The
polarity was changed from n-hexane to EtOAc by increasing the EtOAc
percentages by 10% (v/v), after each 250mL, and then by EtOAc to
MeOH with a 30% (v/v) increase. Following this procedure, 11 frac-
tions were collected (A-M): A (375mg), B (120mg), C (68mg), D
(75mg), E (121mg), F (90mg); G (77mg), H (89mg), I (111mg), L
Fig. 1. Chemical structures of xanthohumol A (left)
and xanthohumol D (right).
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(221mg), M (300mg). The most active fraction, fraction D (75mg,
0.25%), was further purified on a HPLC equipped with RI detector and a
Gemini 10 µm column and eluted with H2O-MeOH (2:8) to obtain pure
xanthohumol A (59mg, 0.20%) and xanthohumol D (6.8 mg, 0.023%)
(Fig. 1B).
2.5. HPLC-DAD and LC-MS analysis
HPLC-DAD analyses of samples obtained from hydroalcoholic
extraction were performed at room temperature on a Jasco PU 1580
HPLC system, equipped with MD-1510 PDA detector and Lichrocart®
RP-18 column (250× 4.6 mm, 3 µm, Merck KGaA, Darmstadt,
Germany). A binary mixture composed of 0.1% formic acid in water
(A) and pure acetonitrile (B) was used for elution, applying the fol-
lowing gradient program: 0–10 min B 10–15%, 10–45 min B 15–40%,
45–52 min B 40–100% and 52–58 min B 100%, at a flow rate of
0.6 mL/min. LC-MS analyses were performed on a Thermo Finnigan
LC-MS system, equipped with a PDA detector and an LCQ Advantage
(ESI+ ionization, fleet ion trap) mass spectrometer, using the same
column and gradient conditions reported above. Evaluation of xan-
thohumol concentrations were performed by comparison with known
solutions of each pure xanthohumol isomer, obtained by further
purification of hop extract (Forino et al., 2016). LC-ESI-MS condi-
tions for analysis were: Capillary Temperature 275 °C, Source Heater
Temperature 150 °C, Sheath Gas Flow 20.0 (Arb.Unit), Aux Gas Flow
10.0 (Arb.Unit), Source voltage 4 kV, Source Current 100 μA, Capil-
lary Voltage 50 V.
2.6. Cytotoxicity
The integrity of the cell morphology before and after treatment was
assessed by light microscope inspection. Cell viability was measured,
after 6 h treatment, by the 3,4,5-dimethylthiazol-2-yl-2-5-diphenylte-
trazolium bromide (MTT) method. This method evaluates the activity of
a mitochondrial enzyme, which is an index of cell viability. The con-
centrations of the extracts which resulted cytotoxic were excluded from
other biological assays.
2.7. Cell culture and IL-8 release measurement
AGS cells were grown at 37 °C in DMEM F12 supplemented with 100
units penicillin per mL, 100mg streptomycin per mL, 2mM L-gluta-
mine, and 10% heat-inactivated FBS (Euroclone S.p.A, Pero, Italy),
under a humidified atmosphere containing 5% CO2.
Cells were grown in 24-well plates for 48 h (30,000 cells per well)
before the cytokine treatment. The IL-8 secretion, induced by TNFα
at 10 ng/mL, was tested after 6 h treatment in the presence of un-
digested or digested extracts (0.1–50 μg/mL). EGCG (10 μM) was
used as the reference inhibitor (Bulgari et al., 2012; Fumagalli et al.,
2016) of IL-8 secretion (50% inhibition). IL-8 was quantified using a
Human Interleukin-8 ELISA Development Kit as described below.
Briefly, Corning 96 well EIA/RIA plates from Sigma-Aldrich (Milan,
Italy) were coated with the antibody provided in the ELISA Kit (Pe-
protech Inc., London, UK) overnight at 4 °C. After blocking the re-
action, 200 μl of samples in duplicate were transferred into wells at
room temperature for 1 h. The amount of IL-8 in the samples was
detected by spectroscopy (signal read: 450 nm, 0.1 s) by the use of
biotinylated and streptavidin–HRP conjugate antibodies, evaluating
the 3,3′,5,5′-tetramethylbenzidine (TMB) substrate reaction. Quan-
tification of IL-8 was done using an optimized standard curve sup-
plied with the ELISA Kit (8.0–1000.0 pg/mL).
2.8. Transient transfection assay
To evaluate the NF-κB driven transcription and IL-8 promoter ac-
tivity, AGS cells were plated in 24-well plates (30,000 cells per well);
after 48 h, cells were transfected by the calcium-phosphate method with
100 ng per well of native IL-8-LUC or 50 ng per well of NF-κB-LUC, the
latter containing the luciferase reporter gene under the control of a NF-
κB responsive promoter (E-selectin promoter). The plasmid NF-κB-LUC
was a gift of Dr. N. Marx (Department of Internal Medicine-Cardiology,
University of Ulm, Ulm, Germany). After 16 h, the cells were treated
with the stimulus (TNFα 10 ng/mL) and the extract for 6 h. EGCG
(10 μM) was used as the reference inhibitor (75% inhibition for NF-κB-
LUC driven transcription). At the end of this time, cells were lysed, and
the luciferase assay was performed using the BriteliteTM Plus reagent
(PerkinElmer Inc., Walthman, MA, USA) according to the manu-
facturer’s instructions. Data were expressed considering 100% of the
luciferase activity related to the cytokine-induced promoter activity.
2.9. Evaluation of NF-κB nuclear translocation
For the NF-κB (p65) nuclear translocation assay, AGS cells were
plated at the concentration of 1.5× 106 cells/ml in 60-mm plates. After
48 h, cells were treated for 1 h with the inflammatory mediator (TNFα
10 ng/mL) and the extracts under study. Nuclear extracts were pre-
pared using Nuclear Extraction Kit from Cayman Chemical Company
(Michigan, USA) and stored at −80 °C until assayed. The same quantity
of total nuclear proteins, measured by Bradford assay, was used to as-
sess NF-κB nuclear translocation using the NF-κB (p65) transcription
factor assay kit (Cayman), followed by spectroscopy analysis (signal
read 450 nm, 0.1 s). Data were expressed considering 100% the absor-
bance related to the cytokine-induced NF-κB nuclear translocation.
EGCG (10 μM) was used as the reference inhibitor (85% inhibition for
NF-κB nuclear translocation).
2.10. Simulated in vitro gastric digestion
According to a well-established protocol, the gastric digestion was
simulated using an in vitro approach previously described (Sangiovanni
et al., 2015). Briefly, the extract (100mg) was incubated for 5min at
37 °C with 6mL of saliva juice, then 12mL gastric juice were added to
the suspension and the sample was incubated for 2 h at 37 °C. At the end
of the incubation, the digested sample was centrifuged for 5min at
3000 g and the supernatant frozen and lyophilized. All the samples, at
different steps, were then stored at −20 °C until the use for biological
assays.
2.11. Statistical analysis
All data are expressed as mean ± s.d.; data were analyzed by un-
paired one-way analysis of variance (ANOVA) followed by Bonferroni
as post-hoc test. Statistical analyses were done using GraphPad Prism
5.0 software (GraphPad Software Inc., San Diego, CA, USA) by com-
paring all the conditions with respect to the stimulated control (TNFα),
considering *p < 0.05; **p < 0.01 and ***p < 0.001. The value of
p < 0.05 was considered statistically significant. IC50 was calculated
using GraphPad Prism 5.00 software.
3. Results and discussion
Dried inflorescence powder of Humulus lupulus cv. Cascade was
extracted with two different solvent mixtures, water (aqueous extract)
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and ethanol/water (50:50) (hydroalcoholic extract), two solvents sui-
table for human consumption, and the yields of extraction were re-
spectively 19.66% and 29.96%. Both the extracts preliminarily revealed
lack of cytotoxicity on the gastric cell model (AGS), till the maximal
concentration tested of 100 μg/mL (data shown in Supplementary ma-
terials, Fig. S1).
Supplementary data associated with this article can be found, in the
online version, at https://doi.org/10.1016/j.jff.2019.03.041.
In order to evaluate the potential anti-inflammatory effects of hops,
cells were challenged with TNFα in the presence of different con-
centrations of extract. As shown in Fig. 2A, the hydroalcoholic extract
inhibited the release of IL-8 in a concentration dependent manner, with
an IC50 of 3.95 μg/mL, while the aqueous extract did not show any
inhibitory effect till the highest concentration tested of 50 μg/mL. On
the contrary, when a reporter plasmid containing the IL-8 promoter
region was used, both the extracts were active, completely inhibiting
the effect of TNFα at 10 μg/mL. IC50 values revealed that the hydro-
alcoholic extract was slightly more active compared to the aqueous one
(2.34 and 3.59 μg/mL, respectively) and this effect was obtained in the
same range of the protein release inhibition (Fig. 2B).
To investigate the molecular mechanism underlying the effects ob-
served on IL-8, we investigated the ability of hop extracts to impair the
NF-κB pathway. This transcription factor plays a central role in reg-
ulating IL-8 gene in several cell models, including gastric epithelial
cells. Hop extracts reduced the transcription of the luciferase gene
controlled by NF-κB-LUC plasmid, which contains a promoter region
strictly dependent on the NF-κB, and the effect was obtained in a range
of concentrations comparable to those described with IL-8-LUC.
Hydroalcoholic extract reduced the transcription with IC50 of 2.44 μg/
mL, similarly to the aqueous extract (IC50 2.25 μg/mL) as shown in
Fig. 3A. Surprisingly, the effect of the extracts on the inhibition of the
NF-κB nuclear translocation, a former step in the inflammatory acti-
vation, required higher concentrations to be achieved.
As depicted in Fig. 3B, only the highest concentration tested
(100 μg/mL) brought the amount of nuclear NF-κB close to the level of
the unstimulated control. In this case, both the extracts required more
than ten times higher concentrations to impair NF-κB translocation,
compared to the inhibitory effect shown on NF-κB driven transcription,
resulting in IC50s of 33.88 and 42.32 μg/mL, respectively for hydro-
alcoholic and aqueous extracts.
These results suggest that hop extracts have the potential to inhibit
NF-κB mostly by affecting the gene transcription mediated by this
factor.
Even if the effect of the extracts was comparable when administered
simultaneously to TNFα, except for IL-8 secretion, the situation ap-
peared different when extracts were used as pre-treatment. Although
both generally less effective, hydroalcoholic extract applied for 1 h
before the inflammatory stimulus was more active in reducing the IL-8
promoter activity (Fig. 4A) and the NF-κB driven transcription (Fig. 4B)
(IC50s of 9.60 μg/mL and 8.11 μg/mL, respectively) in comparison to
the aqueous one (IC50s of 34.91 μg/mL and 36.82 μg/mL, respectively).
However, one-hour pre-treatment with the hydroalcoholic extract did
not inhibit IL-8 release, even at the maximal concentration tested
(50 μg/mL) as shown in Fig. 4C. As expected, the aqueous extract was
inactive as well.
On the basis of the previous results, the hydroalcoholic extract
Fig. 3. Inhibitory effect of the hydroalcoholic
(black bars) and aqueous (white bars) extracts from
hop on NF-κB driven transcription (A) and their
effect on NF-κB nuclear translocation (B), both in-
duced by TNFα in gastric epithelial cells. Results
are expressed as percentage of the TNFα stimulated
condition. EGCG (10 μM) was used as the reference
inhibitor (75% inhibition for NF-κB-LUC driven
transcription and 85% for nuclear translocation).
Fig. 2. Inhibitory effect of the hydroalcoholic
(black bars) and aqueous (white bars) extracts on
IL-8 release induced by TNFα in gastric epithelial
cells (A), in comparison to their effect on IL-8
promoter activity (B), measured by the use of a
reporter plasmid regulated by IL-8 promoter region.
Results are expressed as percentage of the TNFα
stimulated condition. EGCG (10 μM) was used as
the reference inhibitor (50% inhibition of IL-8 se-
cretion and 15% for IL-8 promoter activity).
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resulted the most promising for the anti-inflammatory activity at gastric
level and it was selected for further investigations. Since gastric en-
vironment may alter the bioactivity of compounds occurring in the
extract, due to low pH and the presence of digestive enzymes, we in-
vestigated the effect of an in vitro simulated gastric digestion on the
bioactivity of the hydroalcoholic extract. The digested extract was then
evaluated on IL-8 release inhibition, as the final step of the in-
flammatory cascade. As evident in Fig. 4D, the simulated gastric di-
gestion showed only slight alteration of the activity of the hydroalco-
holic extract, increasing the IC50 of IL-8 inhibition from 3.95 μg/mL to
6.40 μg/mL. This result strengthens the possibility of using the hydro-
alcoholic extract from cv. Cascade hop as anti-inflammatory agent at
gastric level.
As expected, the hydroalcoholic extract is a complex mixture of
secondary metabolites (Fig. 5A and B). According to mass spectral data
and data reported in literature (Li & Deinzer, 2007; Magalhaes et al.,
2010), some major peaks were assigned as follows: (1) Procyanidin
(epicatechin/catechin); (2) Quercetin-3-O-rutinoside; (3) Apigenin-6,8-
di-C-glucoside; (4) Quercetin-3-O-hexoside; (5) Kaempferol-3-O-ruti-
noside; (6) Quercetin-3-O-(6″-malonyl) glucoside; (7) Kaempferol-3-O-
hexoside; (8) Kaempferol-3-O-(6″-malonyl) glucoside; (9) Xanthohumol
D; (10) Xanthohumol A. In particular, xanthohumol A and xanthohumol
D corresponded to 1.86% and 0.28% of the hydroalcoholic extract.
To identify the bioactive compounds, the total hydroalcoholic ex-
tract was fractionated by silica gel column chromatography affording
11 fractions, which were tested for their ability to impair IL-8 release.
The analysis on the fractions revealed that only three fractions, C, D
and, in much lesser extent, L, significantly inhibited the secretion
(Fig. 6A). Considering that fraction C and D, given their consecutive
elution, most likely contain similar compounds, we tested the effect of
fraction D, the most active, and L at different concentrations in the
same model. Fraction D (Fig. 6B), in agreement with preliminary
screening, showed higher effect compared to fraction L (Fig. 6C) with
an IC50 more than six times lower (IC50 of 1.93 μg/mL and 12.41 μg/
mL, respectively). HPLC purification of fraction D revealed that this
fraction was mainly composed by xanthohumol A, but it also contained
minor amounts (about 10%) of xanthohumol D. These compounds were
identified on the basis of the comparison of their 1H NMR spectra with
those reported in the literature (Kupse & Erhardt, 2007; Nookandeh
et al., 2004).
These molecules were purified and separately evaluated on IL-8
secretion (Fig. 7A and B) and both were able to reduce this parameter,
but not to completely inhibit the secretion even at the highest con-
centration tested of 50 μM. Considering 50 μg/mL of the hydroalcoholic
extract, only xanthohumol A reached a concentration of micromolar
level, making this molecule capable of contributing to the biological
activity. These results suggest otherwise that other molecules could
participate in the biological activity of the extract and we cannot ex-
clude that very minor components of the fraction D could significantly
contribute to its activity. Hop prenylflavonoids are efficiently extracted
by hydroalcoholic solutions (Biendl, 2013), thus explaining why hy-
droalcoholic are more active than aqueous extracts.
To the best of our knowledge, this is the first study demonstrating
the anti-inflammatory activity of xanthohumol D in human gastric
epithelial cells. Many literature studies have investigated the biological
properties of xanthohumol A, which is mostly known for its anti-pro-
liferative activity in different cancer cell lines, including gastric cells
(Wei et al., 2018).
Fig. 4. Inhibitory effect of one-hour pretreatment of
hydroalcoholic (black bars) and aqueous (white
bars) extracts from hop on IL-8 promoter activity
(A), NF-κB driven transcription (B) and IL-8 secre-
tion (C), induced by TNFα in gastric epithelial cells.
Effect on IL-8 secretion of the simulated gastric di-
gestion protocol applied to hydroalcoholic extract
(grey bars) in comparison with the non-digested
hydroalcoholic extract (black bar), measured during
TNFα co-treatment (D). Results are expressed as
percentage of the TNFα stimulated condition. EGCG
(10 μM), one-hour pretreatment, was used as the
reference inhibitor (42% inhibition for IL-8 secre-
tion, 50% inhibition for NF-κB-LUC driven tran-
scription and 18% for IL-8 promoter activity).
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According to the literature, the effect of xanthohumol A on IL-8 was
investigated in non-gastric cell lines, such as pancreatic adenocarci-
noma cells (Saito et al., 2018) and hepatic carcinoma cells (Dorn, Weiss
et al., 2010), and in both cases the effect was partially mediated by NF-
κB inhibition. The different concentrations of the hydroalcoholic extract
required to inhibit NF-κB and IL-8 could be explained by the multilevel
control mechanism of this chemokine. IL-8 gene in human cells is
controlled by different transcription factors such as NF-κB, NF-IL6,
nuclear factor-κB repressing factor (NRF) and Activator protein 1 (AP-
1) (Jundi & Greene, 2015; Yasumoto et al., 1992a,b; Matsusaka et al.,
1993). Furthermore, IL-8 mRNA is stabilized by the activity of p38
mitogen-activated protein kinase (p38 MAPK) (Jundi & Greene, 2015).
Activation of NF-κB is known to be regulated by reactive oxygen species
(ROS) and xanthohumol A may act in opposite directions in this con-
text. In fact this molecule causes in vitro the overproduction of ROS,
targeting the mitochondrial complex I, a mechanism which is involved
in apoptosis of cancer cells (Zhang, Chu, Wei, Liu, & Wei, 2015), but it
also induces the transcription of cellular antioxidant enzymes through
the modulation of nuclear factor (erythroid-derived 2)-like 2 (NRF2), in
different cellular models (Krajka-Kuzniak, Paluszczak, & Baer-
Dubowska, 2013; Lee et al., 2011; Yao, Zhang, Ge, Peng, & Fang, 2015).
4. Conclusion
Despite the mechanism of action has not been fully clarified, the
hydroalcoholic extract investigated in the present study, in particular
fraction D, showed a positive effect in the downregulation of IL-8 se-
cretion, in particular acting on the NF-κB pathway. This effect could be
partially explained by the prenylated chalcones content, especially
xanthohumol A and xanthohumol D, however the contribution of other
molecules to the biological activity cannot be excluded.
Our findings demonstrate that the hydroalcoholic extract of cv.
Cascade hop may potentially inhibit the inflammatory reaction at gas-
tric level, although further investigations are needed in order to better
clarify contribution of other compounds in the biological activity and
their mechanism of action.
Fig. 5. HPLC-UV profile of the hydroalcoholic extract: flavonoid (A) and prenylflavonoid region (B). According to mass spectral data and data reported in literature,
peaks were assigned as follows: (1) Procyanidin (epicatechin/catechin); (2) Quercetin-3-O-rutinoside; (3) Apigenin-6,8-di-C-glucoside; (4) Quercetin-3-O-hexoside;
(5) Kaempferol-3-O-rutinoside; 6) Quercetin-3-O-(6″-malonyl) glucoside; (7) Kaempferol-3-O-hexoside; (8) Kaempferol-3-O-(6″-malonyl) glucoside; (9)
Xanthohumol D; (10) Xanthohumol A.
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